GBIO logo

Generation Bio Co (GBIO)

Profile

Full Name

Generation Bio Co.

Ticker Symbol

GBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 12, 2020

Indexes

Not included

Website

http://generationbio.com

Employees

115

Key Details

Price

$0.35(-5.71%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$19.89M(+236.92% YoY)

Annual EPS

-$1.98(-1.02% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.35
GBIO price is $0.35

30-Day Relative Volume

0.74
GBIO 30-day relative volume is 0.74

Price Performance

Price Most recent change

-5.71%
GBIO price was down -5.71% on Apr 16, 2025

Price YTD change

-67.26%
GBIO price is down -67.26% since January 1st

Price 1-year change

-88.36%
GBIO price is down -88.36% year-on-year

Price 3-year change

-96.31%
GBIO price is down -96.31% over the past 3 years

Price Range

Price All-time high

$55.72
GBIO price is currently -99.38% below its historical high of $55.72

Price 3-year low

$0.32
GBIO price is currently +9.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$23.25M
GBIO market capitalization is $23.25 million

Market cap 3-year change

-95.67%
GBIO market capitalization is down -95.67% over the past 3 years

Market cap All-time high

$2.40B
GBIO market capitalization is currently -99.03% below its historical high of $2.40 billion

Market cap sector rank

29.28%
GBIO market capitalization is higher than 29.28% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.78%
GBIO shares outstanding is up +0.78% year-on-year

Shares Outstanding 3-Year Change

+17.4%
GBIO shares outstanding is up +17.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.88
GBIO beta is 1.88

200-day SMA

$1.65
GBIO price is currently -78.97% below its 200-day simple moving average

50-day SMA

$0.52
GBIO price is currently -33.50% below its 50-day simple moving average

RSI

35.32
GBIO 14-day relative strength index is 35.32

Volume

0.74
GBIO 30-day relative volume is 0.74

ATR

$0.05
GBIO average true range is $0.05

10-day Historical Volatility

141.61%
GBIO 10-day historical volatility is 141.61%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$19.89M
GBIO annual revenue is $19.89 million

Revenue Analysts estimate

$5.68M
GBIO annual revenue is currently +250.15% higher than the consensus analysts' forecast

Revenue 1-year change

+236.92%
GBIO annual revenue is up +236.92% year-on-year

Revenue Sector rank

34.38%
GBIO annual revenue is higher than 34.38% of companies in Healthcare sector

EPS

EPS

-$1.98
GBIO annual earnings per share is -$1.98

EPS Analysts estimate

-$0.59
GBIO annual earnings per share is currently +234.91% higher than the consensus analysts' forecast

EPS 1-year change

-1.02%
GBIO annual earnings per share is down -1.02% year-on-year

EPS Sector rank

39.01%
GBIO annual earnings per share is higher than 39.01% of companies in Healthcare sector

Profit

Gross profit

-
GBIO annual gross profit value is unknown

Gross margin

-
GBIO annual gross profit margin value is unknown

Operating profit

-$79.19M
GBIO annual operating income is -$79.19 million

Operating margin

-398.11%
GBIO annual operating profit margin is -398.11%

Net income

-$131.67M
GBIO annual net profit is -$131.67 million

Net margin

-661.91%
GBIO annual net profit margin is -661.91%

Expenses

Total expenses

$99.08M
GBIO annual total expenses is $99.08 million

Operating expenses

$99.08M
GBIO annual total operating expenses is $99.08 million

Cost of goods sold

-
GBIO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$37.78M
GBIO annual SGA is $37.78 million

Depreciation and amortization

$4.93M
GBIO annual depreciation & amortization is $4.93 million

Interest expense

-
GBIO annual interest expense value is unknown

Income tax

-
GBIO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$79.19M
GBIO annual earnings before interest & taxes is -$79.19 million

EBITDA

-$74.26M
GBIO annual EBITDA is -$74.26 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$231.20M
GBIO annual total assets is $231.20 million

Non current assets

$38.29M
GBIO annual long term assets is $38.29 million

Current assets

$192.90M
GBIO annual total current assets is $192.90 million

Cash and cash equivalents

$76.30M
GBIO annual cash & cash equivalents is $76.30 million

Accounts receivable

-
GBIO annual accounts receivable value is unknown

Inventory

-
GBIO annual inventory value is unknown

Liabilities

Total liabilities

$144.99M
GBIO annual total liabilities is $144.99 million

Long term liabilities

$109.94M
GBIO annual total long term liabilities is $109.94 million

Current liabilities

$35.05M
GBIO annual total current liabilities is $35.05 million

Accounts payable

$1.41M
GBIO annual accounts payable is $1.41 million

Debt

Total debt

$93.56M
GBIO annual total debt is $93.56 million

Total debt 1-year change

-4.43%
GBIO annual total debt is down -4.43% year-on-year

Long term debt

$80.55M
GBIO annual long term debt is $80.55 million

Short term debt

$13.01M
GBIO annual short term debt is $13.01 million

Equity & Capital

Shareholders equity

$86.20M
GBIO annual stockholders equity is $86.20 million

Book value

$86.20M
GBIO annual book value is $86.20 million

Retained earnings

-$703.04M
GBIO annual retained earnings is -$703.04 million

Working capital

$157.85M
GBIO annual working capital is $157.85 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$88.56M
GBIO annual cash flow from operations is -$88.56 million

Cash from operations 1-year change

-67.91%
GBIO annual cash flow from operations is down -67.91% year-on-year

Cash from investing

$94.53M
GBIO annual cash flow from investing activities is $94.53 million

Cash from investing 1-year change

+1074.73%
GBIO annual cash flow from investing activities is up +1074.73% year-on-year

Cash from financing

$250.00K
GBIO annual cash flow from financing activities is $250.00 thousand

Cash from financing 1-year change

-99.3%
GBIO annual cash flow from financing activities is down -99.3% year-on-year

CAPEX

CAPEX

$2.40M
GBIO annual capital expenditures is $2.40 million

CAPEX 1-year change

-67.54%
GBIO annual capital expenditures is down -67.54% year-on-year

Free Cash Flow

Free cash flow

-$90.96M
GBIO annual free cash flow is -$90.96 million

Free cash flow 1-year change

-51.25%
GBIO annual free cash flow is down -51.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GBIO annual gross profit margin value is unknown

Operating margin

-398.11%
GBIO annual operating profit margin is -398.11%

Net margin

-661.91%
GBIO annual net profit margin is -661.91%

ROA & ROE

ROA

-43.46%
GBIO annual return on assets is -43.46%

ROE

-91.02%
GBIO annual return on equity is -91.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GBIO price to earnings ratio value is unknown

PE ratio Sector rank

-
GBIO price to earnings ratio is unknown

PB Ratio

PB ratio

0.27
GBIO price to book ratio is 0.27

PB ratio Sector rank

22.57%
GBIO price to book ratio is higher than 22.57% of companies in Healthcare sector

PS Ratio

PS ratio

1.17
GBIO price to sales ratio is 1.17

PS ratio Sector rank

30.77%
GBIO price to sales ratio is higher than 30.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$40.51M
GBIO enterprise value is $40.51 million

Enterprise value Sector rank

39.22%
GBIO enterprise value is higher than 39.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.55
GBIO EV/EBITDA is -0.55

EV/EBITDA Sector rank

50%
GBIO EV/EBITDA is higher than 50% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.50
GBIO annual current ratio is 5.50

Quick ratio

-
GBIO annual quick ratio value is unknown

Leverage

Debt to equity

0.00
GBIO annual debt to equity ratio is 0.00

Interest coverage ratio

-
GBIO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
GBIO piotroski f-score value is unknown

Altman Z-Score

-4.39
GBIO altman z-score is -4.39

Analyst ratings

Recent major analysts updates

Apr 10, 25 Needham
Buy
Mar 17, 25 Canaccord Genuity
Buy
Mar 14, 25 Needham
Buy
Mar 14, 25 Citizens Capital Markets
Market Perform
Jan 8, 25 Needham
Buy
Oct 23, 24 Needham
Buy
Aug 8, 24 Wedbush
Outperform
Aug 8, 24 Needham
Buy
May 14, 24 Wedbush
Outperform
May 14, 24 Needham
Buy

Institutional Ownership

Similar stocks

CGTX logo
Cognition Therapeutics (CGTX)
IGC logo
India Globalization Capital (IGC)
JUNS logo
Jupiter Neurosciences (JUNS)
QTTB logo
Q32 Bio (QTTB)
NRSN logo
NeuroSense Therapeutics (NRSN)
KALA logo
Kala Pharmaceuticals (KALA)
DRRX logo
DURECT (DRRX)
DOMH logo
Dominari Holdings (DOMH)
NXL logo
Nexalin Technology (NXL)
  • What is the ticker symbol for Generation Bio Co?
  • Does Generation Bio Co pay dividends?
  • What sector is Generation Bio Co in?
  • What industry is Generation Bio Co in?
  • What country is Generation Bio Co based in?
  • When did Generation Bio Co go public?
  • Is Generation Bio Co in the S&P 500?
  • Is Generation Bio Co in the NASDAQ 100?
  • Is Generation Bio Co in the Dow Jones?
  • When was Generation Bio Co's last earnings report?
  • When does Generation Bio Co report earnings?
  • Should I buy Generation Bio Co stock now?

What is the ticker symbol for Generation Bio Co?

The ticker symbol for Generation Bio Co is NASDAQ:GBIO

Does Generation Bio Co pay dividends?

No, Generation Bio Co does not pay dividends

What sector is Generation Bio Co in?

Generation Bio Co is in the Healthcare sector

What industry is Generation Bio Co in?

Generation Bio Co is in the Biotechnology industry

What country is Generation Bio Co based in?

Generation Bio Co is headquartered in United States

When did Generation Bio Co go public?

Generation Bio Co's initial public offering (IPO) was on June 12, 2020

Is Generation Bio Co in the S&P 500?

No, Generation Bio Co is not included in the S&P 500 index

Is Generation Bio Co in the NASDAQ 100?

No, Generation Bio Co is not included in the NASDAQ 100 index

Is Generation Bio Co in the Dow Jones?

No, Generation Bio Co is not included in the Dow Jones index

When was Generation Bio Co's last earnings report?

Generation Bio Co's most recent earnings report was on Mar 13, 2025

When does Generation Bio Co report earnings?

The next expected earnings date for Generation Bio Co is May 13, 2025

Should I buy Generation Bio Co stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page